Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$214,645
-$14,332,196 QoQ
Shares Held
102,701
+97.1% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#2,813
of 3,140 holders
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Derivatives in AMGN
reported options exposure · as of Jun 30, 2026CallValue
$3,621,200
CallShares
10,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DIADEMA PARTNERS LP holds $10,595,985 across 3 Drug Manufacturers - General names. AMGN ranks #3 (2.0% of the industry book) .
All Filings in AMGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $214,645 | 102,701 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $3,621,200 | 10,000 | Call | Sole | 2026-08-14 | |
| 2025-06-30 | $17,338,941 | 62,100 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $14,546,841 | 52,100 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $32,183,115 | 103,300 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $16,231,755 | 52,100 | Put | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||